Halozyme Therapeutics Inc (HALO) — Tangible Net Worth Ratio
Halozyme Therapeutics Inc (HALO) has a Tangible Net Worth Ratio of 30.8% as of September 2025. This metric is calculated by deducting intangible assets ($348.54 Million) from net assets ($503.92 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore HALO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Halozyme Therapeutics Inc Tangible Net Worth Ratio (2001–2024)
This chart shows how Halozyme Therapeutics Inc's Tangible Net Worth Ratio has changed across 22 annual periods from 2001 to 2024. As of September 2025, the ratio stands at 30.8%, reflecting net assets of $503.92 Million with intangible assets of $348.54 Million USD. For live market cap and overall valuation, see market value of Halozyme Therapeutics Inc.
Annual Tangible Net Worth Ratio for Halozyme Therapeutics Inc (2001–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Halozyme Therapeutics Inc from 2001 to 2024, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Halozyme Therapeutics Inc (HALO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -10.4% | $363.82 Million | $401.83 Million | $2.06 Billion | ▲ +453.8 pp |
| 2023 | -464.2% | $83.81 Million | $472.88 Million | $1.73 Billion | ▼ -242.3 pp |
| 2022 | -221.9% | $169.80 Million | $546.65 Million | $1.84 Billion | ▼ -321.9 pp |
| 2021 | 100.0% | $196.95 Million | $0.00 | $1.10 Billion | ▲ +0.0 pp |
| 2020 | 100.0% | $151.05 Million | $0.00 | $579.92 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $91.77 Million | $0.00 | $565.87 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $248.89 Million | $0.00 | $440.25 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $208.37 Million | $0.00 | $519.95 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $43.00 Million | $0.00 | $181.79 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $41.35 Million | $0.00 | $165.98 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $48.85 Million | $0.00 | $134.73 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $10.90 Million | $0.00 | $65.76 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $20.35 Million | $0.00 | $91.35 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $6.90 Million | $0.00 | $77.15 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $15.38 Million | $0.00 | $76.56 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $57.77 Million | $0.00 | $103.46 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $23.08 Million | $0.00 | $46.09 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $18.21 Million | $0.00 | $20.51 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $14.82 Million | $0.00 | $16.40 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $10.06K | $0.00 | $47.52K | ▲ +0.0 pp |
| 2002 | 100.0% | $86.81K | $0.00 | $97.25K | ▲ +0.0 pp |
| 2001 | 100.0% | $22.84K | $0.00 | $26.13K | — |